ST Premium

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!

CRVO Company Profile and Key Details

NASDAQ : CRVO

CervoMed Inc.

$14.29

2.73+23.62%

Open: 4:00 PM

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

CRVO Stock Price Chart

Stock Price Today

CervoMed Inc. (CRVO) stock surged +23.62%, trading at $14.29 on NASDAQ, up from the previous close of $11.56. The stock opened at $12.09, fluctuating between $12.09 and $16.94 in the recent session.

Stock Snapshot

11.56

Prev. Close

12.09

Open

17.83M

Market Cap

1.25M

Number of Shares

12.09

Day Low

16.94

Day High

-7.07

P/E Ratio

64.8%

Free Float in %

-2.02

EPS (TTM)

N/A

Book Value

N/A

Cash Flow per Share

7.28M

Volume

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Mar 21, 2025	12.09	16.94	12.05	14.29	7.26M
Mar 20, 2025	9.34	12.27	9.34	11.56	3.36M
Mar 19, 2025	8.95	9.80	8.53	9.37	1.46M
Mar 18, 2025	9.73	10.19	8.78	9.34	5.03M
Mar 17, 2025	7.07	9.51	7.00	9.05	19.92M
Mar 14, 2025	5.74	6.76	5.40	6.44	9.01M
Mar 13, 2025	7.79	7.97	5.62	5.79	57.99M
Mar 12, 2025	2.40	6.84	2.37	6.17	153.93M
Mar 11, 2025	2.16	2.37	1.92	2.36	622.35K
Mar 10, 2025	2.18	2.32	2.13	2.22	630.84K
Mar 07, 2025	2.14	2.24	2.14	2.21	35.52K
Mar 06, 2025	2.13	2.17	2.10	2.15	28.6K
Mar 05, 2025	2.13	2.18	2.09	2.16	34.64K
Mar 04, 2025	2.14	2.18	2.01	2.12	90.05K
Mar 03, 2025	2.24	2.30	2.14	2.14	48.12K
Feb 28, 2025	2.17	2.27	2.12	2.24	56.6K
Feb 27, 2025	2.20	2.26	2.12	2.18	64.3K
Feb 26, 2025	2.18	2.25	2.11	2.22	42.5K
Feb 25, 2025	2.24	2.31	2.17	2.17	77.36K
Feb 24, 2025	2.27	2.31	2.17	2.24	63.11K

Contact Details

Boston, MA 02116

United States

Website: https://www.cervomed.comContact: 617 744 4400

About Company

CervoMed Inc., a clinical-stage biotechnology company, engages in the development and commercialization of drug treatments for neurodegenerative diseases. It develops neflamapimod, an orally administered small molecule brain penetrant for the treatment of dementia with Lewy bodies (DLB), Alzheimer's diseases, and brain stroke recovery. The company is based in Boston, Massachusetts.

Frequently Asked Questions

What is the current CervoMed Inc. (CRVO) stock price?

CervoMed Inc. (NASDAQ: CRVO) stock price is $14.29 in the last trading session. During the trading session, CRVO stock reached the peak price of $16.94 while $12.09 was the lowest point it dropped to. The percentage change in CRVO stock occurred in the recent session was 23.62% while the dollar amount for the price change in CRVO stock was $2.73.

CRVO's industry and sector of operation?

The NASDAQ listed CRVO is part of Biotechnology industry that operates in the broader Healthcare sector. CervoMed Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of CRVO?

No Data

How CRVO did perform over past 52-week?

CRVO's closing price is 693.89% higher than its 52-week low of $1.80 where as its distance from 52-week high of $25.92 is -44.87%.

How many employees does CRVO have?

Number of CRVO employees currently stands at 8.

Link for CRVO official website?

Official Website of CRVO is: https://www.cervomed.com

How do I contact CRVO?

CRVO could be contacted at phone 617 744 4400 and can also be accessed through its website. CRVO operates from 20 Park Plaza, Boston, MA 02116, United States.

How many shares of CRVO are traded daily?

CRVO stock volume for the day was 7.28M shares. The average number of CRVO shares traded daily for last 3 months was 4.53M.

What is the market cap of CRVO currently?

The market value of CRVO currently stands at $17.83M with its latest stock price at $14.29 and 1.25M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

About

Home About Meet The Team Contact Us Privacy Policy Newsletter

Employees	8
Beta	1.83
Sales or Revenue	N/A
5Y Sales Change%	0%
Fiscal Year Ends	N/A
Sector	Healthcare
Industry	Biotechnology